U.S. FDA Counts 62 Deaths That Could Be Tied To Chinese Heparin
This article was originally published in PharmAsia News
Executive Summary
The U.S. FDA says it has received 62 reports of deaths that could be tied to Chinese-produced heparin, more than triple the numbers announced previously. The 62 died within the past 15 months of allergic reactions or low blood pressure, symptoms involved with contaminated heparin. The FDA cautions the heparin may not be the cause of death in all cases. Baxter International recalled most of the product in February, but the drug was produced from basic supplies also shipped to other makers of the drug, such as APP Pharmaceuticals, which said its users were not among the 62 listed by the FDA. (Click here for more
You may also be interested in...
U.S. FDA Triples Estimate On Deaths Following Allergic Reaction To Blood Thinner Heparin
BEIJING - U.S. FDA last week issued a sharply higher estimate on the number of deaths that have occurred in patients who suffered allergic reactions to the blood thinner heparin
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.